L1 cell adhesion molecule as a therapeutic target in cancer

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
   PubMed Web of Science ®Google Scholar
• DeVita VT Jr., Rosenberg SA. Two hundred years of cancer research. N Engl J Med. 2012;366(23):2207–2214.
   PubMed Web of Science ®Google Scholar
• Moos M, Tacke R, Scherer H, et al. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature. 1988;334(6184):701–703.
   PubMed Web of Science ®Google Scholar
• Rathjen FG, Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. Embo J. 1984;3(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hortsch M. The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron. 1996;17(4):587–593.
   PubMed Web of Science ®Google Scholar
• Hauser S, Bickel L, Weinspach D, et al. Full-length L1CAM and not its Delta2Delta27 splice variant promotes metastasis through induction of gelatinase expression. PLoS One. 2011;6(4):e18989.
   PubMed Web of Science ®Google Scholar
• Thelen K, Kedar V, Panicker AK, et al. The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J Neurosci. 2002;22(12):4918–4931.
   PubMed Web of Science ®Google Scholar
• Silletti S, Mei F, Sheppard D, et al. Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment. J Cell Biol. 2000;149(7):1485–1502.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Eggle D, Klostermann S. L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res. 2009;29(12):4919–4931.
   PubMed Web of Science ®Google Scholar
• Gavert N, Ben-Shmuel A, Raveh S, et al. L1-CAM in cancerous tissues. Expert Opin Biol Ther. 2008;8(11):1749–1757.
   PubMed Web of Science ®Google Scholar
• Loers G, Chen S, Grumet M, et al. Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis. J Neurochem. 2005;92(6):1463–1476.
   PubMed Web of Science ®Google Scholar
• Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci. 2007;10(1):19–26.
   PubMed Web of Science ®Google Scholar
• Trinh-Trang-Tan -M-M, Bigot S, Picot J, et al. AlphaII-spectrin participates in the surface expression of cell adhesion molecule L1 and neurite outgrowth. Exp Cell Res. 2014;322(2):365–380.
   PubMed Web of Science ®Google Scholar
• Fransen E, Van Camp G, Vits L, et al. L1-associated diseases: clinical geneticists divide, molecular geneticists unite. Hum Mol Genet. 1997;6(10):1625–1632.
   PubMed Web of Science ®Google Scholar
• Weller S, Gartner J. Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene. Hum Mutat. 2001;18(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ebeling O, Duczmal A, Aigner S, et al. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur J Immunol. 1996;26(10):2508–2516.
   PubMed Web of Science ®Google Scholar
• Pancook JD, Reisfeld RA, Varki N, et al. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J Immunol. 1997;158(9):4413–4421.
   PubMed Web of Science ®Google Scholar
• Maddaluno L, Verbrugge SE, Martinoli C, et al. The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. J Exp Med. 2009;206(3):623–635.
   PubMed Web of Science ®Google Scholar
• Debiec H, Christensen EI, Ronco PM. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. J Cell Biol. 1998;143(7):2067–2079.
   PubMed Web of Science ®Google Scholar
• Kamiguchi H, Long KE, Pendergast M, et al. The neural cell adhesion molecule L1 interacts with the AP-2 adaptor and is endocytosed via the clathrin-mediated pathway. J Neurosci. 1998;18(14):5311–5321.
   PubMed Web of Science ®Google Scholar
• Schaefer AW, Kamiguchi H, Wong EV, et al. Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem. 1999;274(53):37965–37973.
   PubMed Web of Science ®Google Scholar
• Long KE, Asou H, Snider MD, et al. The role of endocytosis in regulating L1-mediated adhesion. J Biol Chem. 2001;276(2):1285–1290.
   PubMed Web of Science ®Google Scholar
• Schaefer AW, Kamei Y, Kamiguchi H, et al. L1 endocytosis is controlled by a phosphorylation-dephosphorylation cycle stimulated by outside-in signaling by L1. J Cell Biol. 2002;157(7):1223–1232.
   PubMed Web of Science ®Google Scholar
• Whittard JD, Sakurai T, Cassella MR, et al. MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth. Mol Biol Cell. 2006;17(6):2696–2706.
   PubMed Web of Science ®Google Scholar
• Bechara A, Nawabi H, Moret F, et al. FAK-MAPK-dependent adhesion disassembly downstream of L1 contributes to semaphorin3A-induced collapse. Embo J. 2008;27(11):1549–1562.
   PubMed Web of Science ®Google Scholar
• Gutwein P, Mechtersheimer S, Riedle S, et al. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. Faseb J. 2003;17(2):292–294.
   PubMedGoogle Scholar
• Heiz M, Grunberg J, Schubiger PA, et al. Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain. J Biol Chem. 2004;279(30):31149–31156.
   PubMed Web of Science ®Google Scholar
• Stoeck A, Keller S, Riedle S, et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J. 2006;393(Pt 3):609–618.
   PubMed Web of Science ®Google Scholar
• Zecchini S, Bianchi M, Colombo N, et al. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res. 2008;68(4):1110–1118.
   PubMed Web of Science ®Google Scholar
• Schneegans T, Borgmeyer U, Hentschke M, et al. Nuclear factor I-A represses expression of the cell adhesion molecule L1. BMC Mol Biol. 2009;10:107.
   PubMed Web of Science ®Google Scholar
• Schafer MK, Altevogt P. L1CAM malfunction in the nervous system and human carcinomas. Cell Mol Life Sci. 2010;67(14):2425–2437.
   PubMed Web of Science ®Google Scholar
• Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012:340296.
   PubMedGoogle Scholar
• Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–695.
   PubMed Web of Science ®Google Scholar
• Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6(6):449–458.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
   PubMed Web of Science ®Google Scholar
• Raveh S, Gavert N, Ben-Ze’ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 2009;282(2):137–145.
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Hazin J, et al. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr. 2012;6(4):374–384.
   PubMed Web of Science ®Google Scholar
• Min JK, Kim JM, Li S, et al. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res. 2010;16(14):3571–3580.
   PubMed Web of Science ®Google Scholar
• Arlt MJ, Novak-Hofer I, Gast D, et al. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res. 2006;66(2):936–943.
   PubMed Web of Science ®Google Scholar
• Mohanan V, Temburni MK, Kappes JC, et al. L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor. Clin Exp Metastasis. 2013;30(4):507–520.
   PubMed Web of Science ®Google Scholar
• Novak-Hofer I, Cohrs S, Grunberg J, et al. Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells. Cancer Lett. 2008;261(2):193–204.
   PubMed Web of Science ®Google Scholar
• Campodonico PB, De Kier Joffe ED, Urtreger AJ, et al. The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer. Mol Carcinog. 2010;49(4):386–397.
   PubMed Web of Science ®Google Scholar
• Gattenloehner S, Chuvpilo S, Langebrake C, et al. Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. Blood. 2007;110(6):2027–2033.
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301–310.
   PubMed Web of Science ®Google Scholar
• Sebens Muerkoster S, Werbing V, Sipos B, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene. 2007;26(19):2759–2768.
   PubMed Web of Science ®Google Scholar
• Sebens Muerkoster S, Kotteritzsch J, Geismann C, et al. alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. Int J Oncol. 2009;34(1):243–253.
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Erbe-Hoffmann N, et al. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene. 2010;29(34):4766–4778.
   PubMed Web of Science ®Google Scholar
• Arlt A, Schafer H. NFkappaB-dependent chemoresistance in solid tumors. Int J Clin Pharmacol Ther. 2002;40(8):336–347.
   PubMed Web of Science ®Google Scholar
• Muerkoster S, Arlt A, Witt M, et al. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer. 2003;104(4):469–476.
   PubMed Web of Science ®Google Scholar
• Stoeck A, Gast D, Sanderson MP, et al. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol. 2007;104(2):461–469.
   PubMed Web of Science ®Google Scholar
• Cheng L, Wu Q, Huang Z, et al. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. Embo J. 2011;30(5):800–813.
   PubMed Web of Science ®Google Scholar
• Yoon H, Min JK, Lee DG, et al. L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells. Cancer Lett. 2012;316(1):70–76.
   PubMed Web of Science ®Google Scholar
• Voura EB, Ramjeesingh RA, Montgomery AM, et al. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell. 2001;12(9):2699–2710.
   PubMed Web of Science ®Google Scholar
• Niu JX, Zhang WJ, Ye LY, et al. The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion. Eur J Cancer Prev. 2007;16(6):517–527.
   PubMed Web of Science ®Google Scholar
• Bergmann F, Wandschneider F, Sipos B, et al. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep. 2010;24(4):909–915.
   PubMed Web of Science ®Google Scholar
• Chen MM, Lee CY, Leland HA, et al. Inside-out regulation of L1 conformation, integrin binding, proteolysis, and concomitant cell migration. Mol Biol Cell. 2010;21(10):1671–1685.
   PubMed Web of Science ®Google Scholar
• Kaifi JT, Reichelt U, Quaas A, et al. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol. 2007;20(11):1183–1190.
   PubMed Web of Science ®Google Scholar
• Siesser PF, Maness PF. L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell Adh Migr. 2009;3(3):275–277.
   PubMed Web of Science ®Google Scholar
• Gast D, Riedle S, Riedle S, et al. L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer. 2005;115(4):658–665.
   PubMed Web of Science ®Google Scholar
• Stoeck A, Schlich S, Issa Y, et al. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. Cancer Lett. 2006;239(2):212–226.
   PubMed Web of Science ®Google Scholar
• Gavert N, Ben-Shmuel A, Lemmon V, et al. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci. 2010;123(Pt 12):2135–2143.
   PubMed Web of Science ®Google Scholar
• Lee SB, Schramme A, Doberstein K, et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol. 2010;130(3):763–773.
   PubMed Web of Science ®Google Scholar
• Yang M, Li Y, Chilukuri K, et al. L1 stimulation of human glioma cell motility correlates with FAK activation. J Neurooncol. 2011;105(1):27–44.
   PubMed Web of Science ®Google Scholar
• Zhao WJ, Schachner M. Neuregulin 1 enhances cell adhesion molecule l1 expression in human glioma cells and promotes their migration as a function of malignancy. J Neuropathol Exp Neurol. 2013;72(3):244–255.
   PubMed Web of Science ®Google Scholar
• Van Der Gaag NA, Rauws EA, Van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362(2):129–137.
   PubMed Web of Science ®Google Scholar
• Dippel V, Milde-Langosch K, Wicklein D, et al. Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells. J Cancer Res Clin Oncol. 2013;139(1):107–121.
   PubMed Web of Science ®Google Scholar
• Ben QW, Wang JC, Liu J, et al. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2010;17(8):2213–2221.
   PubMed Web of Science ®Google Scholar
• Mechtersheimer S, Gutwein P, Agmon-Levin N, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol. 2001;155(4):661–673.
   PubMed Web of Science ®Google Scholar
• Gavert N, Sheffer M, Raveh S, et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 2007;67(16):7703–7712.
   PubMed Web of Science ®Google Scholar
• Gutwein P, Stoeck A, Riedle S, et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res. 2005;11(7):2492–2501.
   PubMed Web of Science ®Google Scholar
• Weinspach D, Seubert B, Schaten S, et al. Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth. Clin Exp Metastasis. 2014;31(1):87–100.
   PubMed Web of Science ®Google Scholar
• Riedle S, Kiefel H, Gast D, et al. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. Biochem J. 2009;420(3):391–402.
   PubMed Web of Science ®Google Scholar
• Shtutman M, Levina E, Ohouo P, et al. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 2006;66(23):11370–11380.
   PubMed Web of Science ®Google Scholar
• Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005;168(4):633–642.
   PubMed Web of Science ®Google Scholar
• Huszar M, Moldenhauer G, Gschwend V, et al. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Hum Pathol. 2006;37(8):1000–1008.
   PubMed Web of Science ®Google Scholar
• Huszar M, Pfeifer M, Schirmer U, et al. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol. 2010;220(5):551–561.
   PubMed Web of Science ®Google Scholar
• Geismann C, Morscheck M, Koch D, et al. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res. 2009;69(10):4517–4526.
   PubMed Web of Science ®Google Scholar
• Gavert N, Vivanti A, Hazin J, et al. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res. 2011;9(1):14–24.
   PubMed Web of Science ®Google Scholar
• Geismann C, Arlt A, Bauer I, et al. Binding of the transcription factor slug to the L1CAM promoter is essential for transforming growth factor-beta1 (TGF-beta)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells. Int J Oncol. 2011;38(1):257–266.
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Pfeifer M, et al. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-kappaB activation. Carcinogenesis. 2012;33(10):1919–1929.
   PubMed Web of Science ®Google Scholar
• Schmid RS, Midkiff BR, Kedar VP, et al. Adhesion molecule L1 stimulates neuronal migration through Vav2-Pak1 signaling. Neuroreport. 2004;15(18):2791–2794.
   PubMed Web of Science ®Google Scholar
• Silletti S, Yebra M, Perez B, et al. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem. 2004;279(28):28880–28888.
   PubMed Web of Science ®Google Scholar
• Kohno M, Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann Med. 2006;38(3):200–211.
   PubMed Web of Science ®Google Scholar
• Ito T, Yamada S, Tanaka C, et al. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ann Surg Oncol. 2014;21(2):560–568.
   PubMed Web of Science ®Google Scholar
• Ben Q, An W, Fei J, et al. Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro. Exp Ther Med. 2014;7(4):785–790.
   PubMed Web of Science ®Google Scholar
• Ben-Shmuel A, Shvab A, Gavert N, et al. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-kappaB signaling that promotes colon cancer progression. Oncogene. 2013;32(27):3220–3230.
   PubMed Web of Science ®Google Scholar
• Gast D, Riedle S, Kiefel H, et al. The RGD integrin binding site in human L1-CAM is important for nuclear signaling. Exp Cell Res. 2008;314(13):2411–2418.
   PubMed Web of Science ®Google Scholar
• Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domain-binding proteins. J Cell Sci. 2000;113(Pt 20):3563–3571.
   PubMed Web of Science ®Google Scholar
• Guarino M. Src signaling in cancer invasion. J Cell Physiol. 2010;223(1):14–26.
   PubMed Web of Science ®Google Scholar
• Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5(10):816–826.
   PubMed Web of Science ®Google Scholar
• Okamoto I, Kawano Y, Murakami D, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol. 2001;155(5):755–762.
   PubMed Web of Science ®Google Scholar
• Sebens S, Schafer H. The tumor stroma as mediator of drug resistance–a potential target to improve cancer therapy? Curr Pharm Biotechnol. 2012;13(11):2259–2272.
   PubMed Web of Science ®Google Scholar
• Bondong S, Kiefel H, Hielscher T, et al. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kappaB activation. Ann Oncol. 2012;23(7):1795–1802.
   PubMed Web of Science ®Google Scholar
• Gavert N, Shvab A, Sheffer M, et al. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis. Cancer Res. 2013;73(18):5754–5763.
   PubMed Web of Science ®Google Scholar
• Kiefel H, Pfeifer M, Bondong S, et al. Linking L1CAM-mediated signaling to NF-kappaB activation. Trends Mol Med. 2011;17(4):178–187.
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Izumoto S, Ohnishi T, et al. Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53. J Clin Pathol. 1998;51(1):13–17.
   PubMed Web of Science ®Google Scholar
• Rawnaq T, Quaas A, Zander H, et al. L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues. J Surg Res. 2012;173(2):314–319.
   PubMed Web of Science ®Google Scholar
• Chen MM, Lee CY, Leland HA, et al. Modification of the L1-CAM carboxy-terminus in pancreatic adenocarcinoma cells. Tumour Biol. 2011;32(2):347–357.
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Morohashi S, Kudo Y, et al. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J Surg Oncol. 2011;103(7):669–673.
   PubMed Web of Science ®Google Scholar
• Fogel M, Gutwein P, Mechtersheimer S, et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet. 2003;362(9387):869–875.
   PubMed Web of Science ®Google Scholar
• Aktas B, Kasimir-Bauer S, Wimberger P, et al. Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer. Anticancer Res. 2013;33(1):329–336.
   PubMed Web of Science ®Google Scholar
• Fogel M, Mechtersheimer S, Huszar M, et al. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett. 2003;189(2):237–247.
   PubMed Web of Science ®Google Scholar
• Zeimet AG, Reimer D, Huszar M, et al. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. J Natl Cancer Inst. 2013;105(15):1142–1150.
   PubMedGoogle Scholar
• Finas D, Huszar M, Agic A, et al. L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis. Hum Reprod. 2008;23(5):1053–1062.
   PubMed Web of Science ®Google Scholar
• Ben-Arie A, Huszar M, Ben-Zvi N, et al. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women. Eur J Surg Oncol. 2008;34(7):795–799.
   PubMed Web of Science ®Google Scholar
• Schirmer U, Fiegl H, Pfeifer M, et al. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens. BMC Cancer. 2013;13:156.
   PubMed Web of Science ®Google Scholar
• Li S, Jo YS, Lee JH, et al. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res. 2009;15(23):7345–7351.
   PubMed Web of Science ®Google Scholar
• Hai J, Zhu CQ, Bandarchi B, et al. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res. 2012;18(7):1914–1924.
   PubMed Web of Science ®Google Scholar
• Tischler V, Pfeifer M, Hausladen S, et al. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer. 2011;10:127.
   PubMed Web of Science ®Google Scholar
• Allory Y, Matsuoka Y, Bazille C, et al. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res. 2005;11(3):1190–1197.
   PubMed Web of Science ®Google Scholar
• Rawnaq T, Kleinhans H, Uto M, et al. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Anticancer Res. 2009;29(4):1195–1199.
   PubMed Web of Science ®Google Scholar
• Kodera Y, Nakanishi H, Ito S, et al. Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res. 2009;29(10):4033–4039.
   PubMed Web of Science ®Google Scholar
• Wang YY, Li L, Zhao ZS, et al. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res. 2013;32(1):66.
   PubMed Web of Science ®Google Scholar
• Chen DL, Zeng ZL, Yang J, et al. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. J Hematol Oncol. 2013;6:43.
   PubMed Web of Science ®Google Scholar
• Schafer H, Struck B, Feldmann EM, et al. TGF-beta1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells. Oncogene. 2013;32(2):180–189.
   PubMed Web of Science ®Google Scholar
• Boo YJ, Park JM, Kim J, et al. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol. 2007;14(5):1703–1711.
   PubMed Web of Science ®Google Scholar
• Dahl A, Teegen J, Altevogt P, et al. Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up-regulation of L1 predicts fatal prognosis. Histopathology. 2011;59(2):299–307.
   PubMed Web of Science ®Google Scholar
• Guo X, Xiong L, Zou L, et al. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagn Pathol. 2012;7:96.
   PubMed Web of Science ®Google Scholar
• Zander H, Rawnaq T, Von Wedemeyer M, et al. Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients. BMC Cancer. 2011;22(11):1–7.
   Google Scholar
• Meier F, Busch S, Gast D, et al. The adhesion molecule L1 (CD171) promotes melanoma progression. Int J Cancer. 2006;119(3):549–555.
   PubMed Web of Science ®Google Scholar
• Gast D, Riedle S, Issa Y, et al. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene. 2008;27(9):1281–1289.
   PubMed Web of Science ®Google Scholar
• Wolterink S, Moldenhauer G, Fogel M, et al. Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res. 2010;70(6):2504–2515.
   PubMed Web of Science ®Google Scholar
• Jung J, Son YS, Park H, et al. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Oncol Rep. 2011;25(4):945–952.
   PubMed Web of Science ®Google Scholar
• Lee ES, Jeong MS, Singh R, et al. A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model. Exp Mol Med. 2012;44(4):293–302.
   PubMed Web of Science ®Google Scholar
• Kim KS, Min JK, Liang ZL, et al. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma. Clin Cancer Res. 2012;18(11):3071–3078.
   PubMed Web of Science ®Google Scholar
• Held-Feindt J, Schmelz S, Hattermann K, et al. The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas. Neurochem Int. 2012;61(7):1183–1191.
   PubMed Web of Science ®Google Scholar
• Doberstein K, Harter PN, Haberkorn U, et al. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT. Int J Cancer. 2014;136(5):E326–E339.
   PubMed Web of Science ®Google Scholar
• Doberstein K, Bretz NP, Schirmer U, et al. miR-21-3p is a positive regulator of L1CAM in several human carcinomas. Cancer Lett. 2014;354(2):455–466.
   PubMed Web of Science ®Google Scholar
• Grunberg J, Novak-Hofer I, Honer M, et al. In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors. Clin Cancer Res. 2005;11(14):5112–5120.
   PubMed Web of Science ®Google Scholar
• Knogler K, Grunberg J, Novak-Hofer I, et al. Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties. Nucl Med Biol. 2006;33(7):883–889.
   PubMed Web of Science ®Google Scholar
• Fischer E, Grunberg J, Cohrs S, et al. L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer. Int J Cancer. 2012;130(11):2715–2721.
   PubMed Web of Science ®Google Scholar
• Hoefnagel CA, Rutgers M, Buitenhuis CK, et al. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001;28(3):359–368.
   Google Scholar
• Knogler K, Grunberg J, Zimmermann K, et al. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res. 2007;13(2 Pt 1):603–611.
   PubMed Web of Science ®Google Scholar
• Grünberg J, Lindenblatt D, Dorrer H, et al. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. Eur J Nucl Med Mol Imaging. 2014;41(10):1907–1915.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, Li Z, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008;68(15):6043–6048.
   PubMed Web of Science ®Google Scholar
• Schafer H, Dieckmann C, Korniienko O, et al. Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer Lett. 2012;319(1):66–82.
   PubMed Web of Science ®Google Scholar
• Altevogt P, Doberstein K, Fogel M. L1CAM in human cancer. Int J Cancer. 2015. doi:10.1002/ijc.29658.).
   Google Scholar